Fierce Pharma Asia—Biocon, Viatris’ insulin biosim launch; AstraZeneca China’s deceleration; Huahai’s FDA warning lift

Fierce Pharma Asia—Biocon, Viatris’ insulin biosim launch; AstraZeneca China’s deceleration; Huahai’s FDA warning lift
aliu
Fri, 11/19/2021 – 07:26